SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

NIGHT is currently capturing significant community attention following its mainnet rollout and integrations with major financial institutions like MoneyGram and Monument Bank, which aim to drive regulated, privacy-focused adoption. While some investors remain cautious due to the heavy influence of Google Cloud in its infrastructure and lingering skepticism from some Cardano community members regarding Charles Hoskinsons leadership, bullish participants are actively discussing the potential of its zero-knowledge technology and upcoming airdrops to catalyze long-term growth.

BlockDAG is a hybrid concept that combines features of both traditional blockchains and DAGs. It retains the benefits of DAGs, such as high scalability and faster transaction processing, while integrating the security and trust of blockchain consensus mechanisms. BlockDAG emerges as a groundbreaking solution, meticulously merging the strengths of both blockchain and DAG architectures. It leverages the robust security and decentralization of blockchains while incorporating the efficient, scalable transaction processing of DAGs. This strategic integration allows blockDAG to handle a significantly higher volume of transactions at faster speeds compared to traditional blockchains. By overcoming the inherent limitations of both technologies, blockDAG paves the way for a future where distributed ledgers can seamlessly scale to meet the ever-growing demands of the cryptocurrency and broader digital landscape.

BlockDAG

BlockDAG is currently trending due to intense community frustration surrounding difficulties with token claims, confusing wallet connectivity, and widespread accusations that the project operates as a scam. While some proponents continue to push the mining app and long-term potential, many investors are actively sharing warnings and seeking legal recourse due to the lack of clear, functional access to their holdings.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors anticipate long-term Week 40 clinical data for their flagship candidate, sonelokimab, which is set to be presented at an upcoming dermatology conference. The community is heavily focused on the drug's potential to establish a 'best-in-class' profile for treating Hidradenitis Suppurativa, with active discussions revolving around institutional accumulation patterns, recent analyst upgrades, and persistent speculation regarding potential M&A interest from major pharmaceutical players.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is currently under downward pressure following a disappointing quarterly earnings report where the company missed profit estimates and lowered its full-year guidance due to weak consumer demand and a stagnant housing market. Community sentiment is deeply divided; while some investors view the current dip as a long-term value opportunity for a sector leader, many traders are actively shorting the stock, citing ongoing macro headwinds, concerns over high-ticket renovation project delays, and a pessimistic outlook for the broader housing sector.

iShares Trust - iShares MSCI India ETF

iShares MSCI India ETF

The iShares MSCI India ETF (INDA) is currently in focus as investors weigh the potential impact of looming U.S. reciprocal tariffs and geopolitical tensions against the nation's robust long-term growth story and ongoing trade deal negotiations. While market participants are actively discussing the risks of foreign equity outflows and currency volatility, many community members remain bullish on India's resilience and its strategic potential as a global manufacturing hub.

PRIME is the native token of the Echelon Prime Foundation, a Web3 ecosystem advancing the next generation of gaming. Echelon creates and distributes tools to encourage innovation in, and promote the growth of, novel gaming models and economies. The first game to adopt and utilize PRIME is Parallel, a sci-fi trading card game.

Echelon Prime

Echelon Prime is capturing significant attention as investors speculate on a major reversal, with the community actively discussing potential growth driven by the project's ongoing development of tools for blockchain-based player economies. Sentiment remains optimistic as participants highlight the token's role within the expanding Web3 gaming sector, viewing current price action as a key accumulation opportunity ahead of potential market rallies.

Borr Drilling Ltd. engages in the provision of offshore drilling services to the oil and gas industry. It operates through Dayrate; and Integrated Well Services (IWS) segments. The Dayrate segment consists of rig charters and ancillary services. The IWS segment provides integrated well services through Opex and Akal. The company was founded by Tor Olav Trøim on August 8, 2016 and is headquartered in Hamilton, Bermuda.

Borr Drilling Ltd

Borr Drilling is capturing market attention as investors weigh the impact of recent contract expansions and a transition in executive leadership against persistent debt concerns. The community remains divided, with many traders actively accumulating shares based on potential upside in the offshore rig market, while others express caution regarding the company's long-term financial leverage.

The Graph is an indexing protocol and global API for organizing blockchain data and making it easily accessible with GraphQL. Developers can use Graph Explorer to search, find, and publish all the public data they need to build decentralized applications. The Graph Network makes it possible to build serverless dApps that run entirely on public infrastructure.  GRT is the native token of the network that’s used to coordinate work. GRT is an ERC20 token. Node operators, called Indexers, stake and earn GRT for processing queries. Anyone can delegate GRT to Indexers to secure the network and earn rewards. Curators organize data on The Graph by signaling GRT on useful APIs, called subgraphs. Indexers, Delegators, and Curators work together to organize the data for the crypto economy and maintain a useful global API for DeFi and Web3.

The Graph

The Graph is capturing attention as community members debate its long-term potential as a foundational web3 data infrastructure play amidst recent technical upgrades like Substreams and integration with Anthropic's Model Context Protocol. While some investors view current price levels as an undervalued accumulation opportunity for the next market cycle, others remain skeptical, pointing to historical supply dilution and persistent sideways price action as ongoing concerns.

Halliburton Co. engages in the provision of products and services to the energy industry. It operates through the Completion and Production, and Drilling and Evaluation segments. The Completion and Production segment focuses on cementing, stimulation, specialty chemicals, intervention, pressure control, artificial lift, and completion products and services. The Drilling and Evaluation segment provides field and reservoir modeling, drilling, fluids, evaluation, and wellbore placement solutions that enable customers to model, measure, drill, and optimize well construction activities. The company was founded by Erle P. Halliburton in 1919 and is headquartered in Houston, TX.

Halliburton Co.

Halliburton is trending as the energy sector evaluates the potential impact of major geopolitical shifts in Venezuela, with investors closely watching how integrated service providers could play a role in infrastructure reconstruction. The community is actively discussing the stock's long-term valuation and strategic position, with some traders monitoring unusual options activity while others debate whether the current price point represents a buying opportunity or a warning sign amid broader market rotation into energy.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is currently under significant investor scrutiny as the stock tests multi-year technical support levels amidst broader healthcare policy uncertainty and skepticism regarding its 2026 path to profitability. While some community members view the current depressed price as an asymmetric opportunity based on long-term membership growth and AI-driven efficiency, others remain vocal about fundamental risks related to medical loss ratios and the sustainability of the company's growth narrative.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization Co-Diagnostics Ships...

EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch

Co-Diagnostics ships PCR Pro and TB test kits to India, advancing clinical studies as the WHO backs NPOC diagnostics.read more...

Penny Stocks To Research - March 22nd

Kosmos Energy, Co-Diagnostics, SELLAS Life Sciences Group, JetBlue Airways, BigBear.ai, Banco Bradesco, and Bitfarms are the seven Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are shares of very small companies that trade at low pricestypically under $5...

Penny Stocks To Watch Now - March 21st

Kosmos Energy, Co-Diagnostics, SELLAS Life Sciences Group, JetBlue Airways, and BigBear.ai are the five Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are...

<ul class="summary-bullets"><li>Co-Diagnostics said the expansion opens up a potential addressable market of around $13 billion.</li><li>The expansion will support the rollout of the PCR Pro point-of-care platform and SARAGENE test products.</li><li>The firm regained compliance with Nasdaq’s minimum bid price requirements earlier this month.</li></ul>Shares of Co-Diagnostics Inc. (CODX) reversed their pre-market gains and fell around 5% on Friday, after the company announced its foray into Bangladesh, Pakistan, Nepal, and Sri Lanka, a move that lifts its total addressable market to an estimated $13 billion.<a href="https://stocktwits.com/symbol/CODX">CODX shares</a> had climbed as high as 45% in pre-market trading.<h2 class="st-heading-2">Expansion Through Indian JV</h2>The biotech company said the expansion will be carried out through its Indian joint venture, CoSara Diagnostics. The expansion will support the rollout of CoSara’s PCR Pro point-of-care platform and SARAGENE test products, pending regulatory approvals. CoSara will host a virtual distributor information session in the second-quarter (Q2) of 2026.Mohal Sarabhai, CEO of CoSara, said that South Asia represents a large and rapidly growing market for molecular diagnostics, with a significant need for easily accessible, non-invasive, quick, and reliable testing solutions.Co-Diagnostics develops advanced diagnostic technologies based on DNA and RNA analysis, and PCR-based tests to detect genetic markers across applications beyond infectious diseases.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits remained in the ‘bullish’ territory over the past 24 hours.One user called the stock’s movement a “classic dead cat rally.”<stembedurl>https://stocktwits.com/Joeloida/message/648083064</stembedurl>According to Fiscal.ai data, the company is expected to post revenue of approximately $160,000 in Q4 and a loss of approximately $3.60 per share. Co-Diagnostics is likely to report its quarterly earnings on March 31.Last week, Co-Diagnostics received a new patent from the Japan Patent Office for its automated biological testing technology, following a similar patent granted in Australia last year. The patent strengthens its intellectual property portfolio and supports its PCR Pro platform, including its testing system and proprietary test cups.Earlier this month, the company said it had regained compliance with Nasdaq’s minimum bid price requirements. It had previously carried out a 1-for-30 reverse stock split, effective Jan. 2, 2026.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart can be seen in a trading platform on a smartphone. Top U.S. firms announced record buybacks this year. (Photo by Silas Stein/picture alliance via Getty Images)

CODX Stock Reverses Pre-Market Gains Driven By South Asia Expansion Deal – Retail Highlights ‘Dead Cat Rally’

The company said it will increase its presence in South Asia through its Indian JV CoSara Diagnostics.

Equity

Co-Diagnostics Expands South Asia Footprint, Targeting $13B Diagnostics Opportunity

CODX (NASDAQ:CODX) is making a strategic push to scale its global diagnostics platform, announcing a major expansion of its commercial and distribution footprint across South Asia through its joint venture, CoSara Diagnostics.

Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution...

Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Lags Revenue Estimates

Sera Prognostics (SERA) delivered earnings and revenue surprises of +5.88% and -75.00%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast PR Newswire...

Co-Diagnostics to Present at Medical Korea 2026

Co-Diagnostics to Present at Medical Korea 2026 Co-Diagnostics to Present at Medical Korea 2026 PR Newswire SALT LAKE CITY, March 16, 2026 Co-Dx to join WTC Utah and other Utah legislative and...

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Co-Diagnostics Inc

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

CODX
Co-Diagnostics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CODX News

CODXCo-Diagnostics Inc